Effect of recombinant human erythropoietin on postoperative anemia in children and adolescents undergoing osteosarcoma and potential influencing factors: a single-center retrospective study
BackgroundRecombinant human erythropoietin (rhEPO) is an active glycoprotein secreted by the kidneys that improves anemia. The therapeutic role of rhEPO in anemia induced by surgical treatment after neoadjuvant chemotherapy in children and adolescents with osteosarcoma remains unclear. Additionally,...
Uloženo v:
| Hlavní autoři: | , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Frontiers Media S.A.
2025-11-01
|
| Edice: | Frontiers in Pharmacology |
| Témata: | |
| On-line přístup: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1637441/full |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|